Literature DB >> 28667070

Pathogenesis of asthma: implications for precision medicine.

Richard J Russell1, Christopher Brightling2.   

Abstract

The pathogenesis of asthma is complex and multi-faceted. Asthma patients have a diverse range of underlying dominant disease processes and pathways despite apparent similarities in clinical expression. Here, we present the current understanding of asthma pathogenesis. We discuss airway inflammation (both T2HIGH and T2LOW), airway hyperresponsiveness (AHR) and airways remodelling as four key factors in asthma pathogenesis, and also outline other contributory factors such as genetics and co-morbidities. Response to current asthma therapies also varies greatly, which is probably related to the inter-patient differences in pathogenesis. Here, we also summarize how our developing understanding of detailed pathological processes potentially translates into the targeted treatment options we require for optimal asthma management in the future.
© 2017 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  airway; asthma; inflammation; pathogenesis; precision medicine; remodelling

Mesh:

Year:  2017        PMID: 28667070     DOI: 10.1042/CS20160253

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  33 in total

Review 1.  The immunopathology of lung fibrosis: amphiregulin-producing pathogenic memory T helper-2 cells control the airway fibrotic responses by inducing eosinophils to secrete osteopontin.

Authors:  Kiyoshi Hirahara; Ami Aoki; Yuki Morimoto; Masahiro Kiuchi; Mikiko Okano; Toshinori Nakayama
Journal:  Semin Immunopathol       Date:  2019-04-09       Impact factor: 9.623

2.  The Saudi Initiative for Asthma - 2019 Update: Guidelines for the diagnosis and management of asthma in adults and children.

Authors:  Mohamed S Al-Moamary; Sami A Alhaider; Abdullah A Alangari; Mohammed O Al Ghobain; Mohammed O Zeitouni; Majdy M Idrees; Abdullah F Alanazi; Adel S Al-Harbi; Abdullah A Yousef; Hassan S Alorainy; Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2019 Jan-Mar       Impact factor: 2.219

Review 3.  Modeling asthma: Pitfalls, promises, and the road ahead.

Authors:  Helene F Rosenberg; Kirk M Druey
Journal:  J Leukoc Biol       Date:  2018-02-16       Impact factor: 4.962

Review 4.  Extracellular Vesicle Associated Non-Coding RNAs in Lung Infections and Injury.

Authors:  Zhi Hao Kwok; Kareemah Ni; Yang Jin
Journal:  Cells       Date:  2021-04-21       Impact factor: 7.666

5.  Interleukin-18, IL-18 binding protein and IL-18 receptor expression in asthma: a hypothesis showing IL-18 promotes epithelial cell differentiation.

Authors:  Davinder Kaur; Latifa Chachi; Edith Gomez; Nicolas Sylvius; Christopher E Brightling
Journal:  Clin Transl Immunology       Date:  2021-06-26

6.  Epithelial cell-derived CD83 restores immune tolerance in the airway mucosa by inducing regulatory T-cell differentiation.

Authors:  Li-Hua Mo; Xiang-Qian Luo; Gui Yang; Jiang-Qi Liu; Li-Teng Yang; Zhi-Qiang Liu; Shuai Wang; Da-Bo Liu; Zhi-Gang Liu; Ping-Chang Yang
Journal:  Immunology       Date:  2021-02-28       Impact factor: 7.215

7.  MicroRNA-221 Modulates Airway Remodeling via the PI3K/AKT Pathway in OVA-Induced Chronic Murine Asthma.

Authors:  Jing Pan; Qianyuan Yang; Yao Zhou; Huan Deng; Yifan Zhu; Deyu Zhao; Feng Liu
Journal:  Front Cell Dev Biol       Date:  2020-06-30

8.  Galectin-1 inhibits PDGF-BB-induced proliferation and migration of airway smooth muscle cells through the inactivation of PI3K/Akt signaling pathway.

Authors:  Xinfeng Pang; Jing Qiao
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

Review 9.  New Perspectives in the Diagnosis and Management of Allergic Fungal Airway Disease.

Authors:  Andrew J Wardlaw; Eva-Maria Rick; Leyla Pur Ozyigit; Alys Scadding; Erol A Gaillard; Catherine H Pashley
Journal:  J Asthma Allergy       Date:  2021-05-25

10.  Role of liver-X-receptors in airway remodeling in mice with chronic allergic asthma.

Authors:  Jinmei Zhang; Zhengcan Wu; Fenfang Yu; Liang Ye; Wei Gu; Yan Tan; Li Wang; Ying Shi
Journal:  Exp Ther Med       Date:  2021-06-30       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.